Key result
Hybrid transatrial transcatheter mitral valve replacement is an evolving alternative for severe mitral annular calcification that mitigates some procedural challenges but remains technically demanding with significant early mortality risk.
Hybrid transatrial TMVR provides a promising intermediate treatment strategy for severe MAC in carefully selected patients, though it remains a technically demanding, off-label procedure requiring multidisciplinary Heart Team expertise.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bacchi et al. (2026) conducted an editorial in Severe mitral annular calcification (MAC). Hybrid transatrial transcatheter mitral valve replacement (TMVR) vs. Conventional surgery or fully percutaneous therapy was evaluated. Hybrid transatrial transcatheter mitral valve replacement is an evolving alternative for severe mitral annular calcification that mitigates some procedural challenges but remains technically demanding with significant early mortality risk.
Synapse has enriched 5 related papers. Consider them for comparative context: